Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India

A good point-of-care diagnostic test holds a promise to reduce inappropriate use of antibiotics by enabling early detection of the pathogen and facilitating rapid testing of antimicrobial susceptibility. India has taken many initiatives in the recent past to augment the development and deployment of diagnostics in Indian health care system. Funding opportunities to promote innovation in diagnostics development were started in early 2000s through various ministries and departments. India released National Essential Diagnostics List which enlists essential tests and there is now Free Diagnostics Service Initiative of Government of India under National Health Mission that mandates to provide all essential tests free of cost. We wanted to understand how these initiatives have impacted the diagnostics that could be of use in containment of antimicrobial resistance (AMR) and whether there is a smooth process for bringing indigenously developed products relevant to AMR into the healthcare system. We conducted a longitudinal survey (January 2019 and January 2021) to understand the availability of market ready indigenous rapid diagnostics for AMR in the country and their progress towards introduction in the private market or uptake in healthcare system. We found that many innovators and developers are working towards development of rapid tests that can be useful in the containment of AMR in India. While there are many promising diagnostics on the horizon, the pathway for uptake of indigenously developed diagnostics in healthcare system remains disjointed and needs to be harmonised for the investments made towards development to translate as tangible gains. Since most of these efforts are government funded, it is incumbent upon the government to also provide a seamless pathway to make these diagnostics available in health care system. In absence of this guidance, most of these diagnostics will sit with the innovators/developers and will never be used for the purpose they were intended to serve

Antibiotic resistance · Business · Economic growth · Economics · Health care · Pathology · Point-of-care testing · Software deployment · Antibiotic Resistance in Bacteria · Antibiotic Use and Resistance · Antimicrobial Resistance in Staphylococcus · Engineering · Medicine

• Nations within a nation

  Open Access•Lalit Dandona, Rakhi Dandona et al.•The Lancet•2017

  Incluir item

• Understanding the mechanisms and drivers of antimicrobial resistance

  Open Access•Alison H Holmes, Luke Moore et al.•The Lancet•2016

  Incluir item

• Aligning diagnostics to the point-of-care

  Open Access•Nora Engel, Petra Wolffs et al.•BMJ Global Health•2020

  Incluir item

• Leapfrogging laboratories

  Open Access•Iruka N Okeke, Nicholas Feasey et al.•BMJ Global Health•2020

  Incluir item

• Bacterial versus non-bacterial infections

  Open Access•Camille Escadafal, Steffen Geis et al.•BMJ Global Health•2020

  Incluir item